Skip to main content
AlzChem Group AG logo

AlzChem Group AG — Investor Relations & Filings

Ticker · ACT ISIN · DE000A2YNT30 LEI · 8945004EL7WZK3ERG181 F Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2024-05-07 AGM Information
Country DE Germany
Listing F ACT

About AlzChem Group AG

https://www.alzchem.com/en

AlzChem Group AG is a globally active, vertically integrated specialty chemicals company focused on NCN (Nitrogen-Carbon-Nitrogen) chemistry. Its production chain is based on raw materials such as calcium carbide and calcium cyanamide, from which it develops a wide range of products. The company serves diverse markets including human and animal nutrition, pharmaceuticals, agriculture, metallurgy, renewable energy, and automotive. Key products include high-purity creatine for dietary supplements (Creapure®), feed additives for animal nutrition (Creamino®), and high-purity guanidine salts used as intermediates for pharmaceutical and diagnostic applications, such as PCR tests. AlzChem also offers custom synthesis services and is a market leader in many of its business segments.

Recent filings

Filing Released Lang Actions
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved
AGM Information Classification · 99% confidence The document explicitly mentions 'Annual General Meeting' multiple times in the headline and body, discussing shareholder support, approval of agenda items, and dividend increase decisions made at this meeting. The keyword 'AGM/EGM' is also present. This strongly indicates the content relates to the proceedings or outcomes of the Annual General Meeting. The most appropriate classification is AGM Information (AGM-R). Although voting results are mentioned, the primary focus is the overall meeting outcome and approvals, making AGM-R more specific than DVA (Declaration of Voting Results & Voting Rights Announcements), which is usually just the results summary. Since this is an announcement summarizing the AGM, AGM-R is the best fit.
2024-05-07 English
Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024
Earnings Release Classification · 100% confidence The document explicitly states it is an announcement regarding the first quarter of 2024 results, using keywords like 'Quarterly / Interim Statement', 'first quarter 2024', and providing key financial highlights (Sales, EBITDA, Free Cash Flow). This content structure aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results. Although it mentions a 'detailed quarterly statement' is available elsewhere, this document itself is the summary release, not the full report (which would be classified as IR). Since it contains the primary financial highlights and management commentary for the period, ER is the most appropriate classification. Q1 2024
2024-04-30 English
Annual financial report 2023
Annual Report Classification · 100% confidence The document is explicitly titled 'ANNUAL REPORT 2023' for Alzchem Group AG. It contains comprehensive sections including the Management Board interview, Supervisory Board report, combined management report, consolidated financial statements, and key financial figures for the fiscal year. It is a full-length annual report, not an announcement or summary. FY 2023
2024-04-04 English
Alzchem Group AG: Bekanntmachung der Einberufung zur Hauptversammlung am 07.05.2024 in Trostberg mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information Classification · 100% confidence The document is explicitly titled 'Bekanntmachung der Einberufung zur Hauptversammlung' (Announcement of the Convocation to the General Meeting) and contains the agenda ('Tagesordnung') for the meeting scheduled for May 7, 2024. It details items typically voted on at an AGM, such as the approval of financial statements, dividend allocation, discharge of management/supervisory boards, and election of auditors. This content directly corresponds to the purpose of an Annual General Meeting (AGM) announcement. Therefore, the classification is AGM-R.
2024-03-25 German
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding
Regulatory Filings Classification · 99% confidence The document is a short announcement dated March 15, 2024, labeled as 'Ad-hoc' and disclosing 'Inside Information' according to MAR Regulation (EU) No 596/2014. The content details that Alzchem Group AG received a significant EU funding grant (EUR 34.4 million) for expanding production capacity related to defense technology precursors. This type of announcement, which is a material, non-public event disclosure required under EU market regulations, is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was purely on the funding mechanism. However, since it is an immediate, ad-hoc disclosure of a material event (EU funding award) that doesn't fit the specific definitions for earnings, dividends, director dealings, or M&A, the most appropriate general regulatory category is RNS. Given the document length (2328 chars) and its nature as a direct disclosure of material information, it is not an announcement *about* a report (RPA), but the report/disclosure itself.
2024-03-15 English
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments
Environmental & Social Information Classification · 99% confidence The document is a press release disseminated via EQS News, dated March 11, 2024, announcing the successful completion of a clinical study phase regarding creatine use in dialysis treatments by Alzchem Group AG and Crearene AG. It details initial results, confirms technical feasibility, and announces an extension of their collaboration. This type of announcement, which communicates significant operational/research updates but is not a formal periodic financial report (like 10-K or IR), nor a specific regulatory filing like a Director's Dealing or Dividend Notice, fits best under the general category for corporate news releases that don't fit elsewhere, which is Regulatory Filings (RNS), as it is explicitly distributed through an EQS Distribution Service that includes 'Financial/Corporate News and Press Releases'. It is not an Earnings Release (ER) as it focuses on R&D progress, not period financial results.
2024-03-11 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.